Tabouret E - Search Results

1

Role of 3D volume growth rate for drug activity evaluation in meningioma clinical trials: the example of the CEVOREM study.

Graillon T, Ferrer L, Siffre J, Sanson M, Peyre M, Peyrière H, Mougel G, Autran D, Tabouret E, Figarella-Branger D, Barlier A, Kalamarides M, Dufour H, Colin T, Chinot O. Graillon T, et al. Among authors: tabouret e. Neuro Oncol. 2021 Jul 1;23(7):1139-1147. doi: 10.1093/neuonc/noab019. Neuro Oncol. 2021. PMID: 33556177 Free PMC article. Clinical Trial.

2

FDG-PET predicts survival in recurrent high-grade gliomas treated with bevacizumab and irinotecan.

Colavolpe C, Chinot O, Metellus P, Mancini J, Barrie M, Bequet-Boucard C, Tabouret E, Mundler O, Figarella-Branger D, Guedj E. Colavolpe C, et al. Among authors: tabouret e. Neuro Oncol. 2012 May;14(5):649-57. doi: 10.1093/neuonc/nos012. Epub 2012 Feb 29. Neuro Oncol. 2012. PMID: 22379188 Free PMC article.

3

Association of carcinoid tumor and low grade glioma.

Tabouret E, Barrié M, Vicier C, Gonçalves A, Chinot O, Viens P, Madroszyk A. Tabouret E, et al. World J Surg Oncol. 2012 Nov 8;10:236. doi: 10.1186/1477-7819-10-236. World J Surg Oncol. 2012. PMID: 23137305 Free PMC article.

4

Recent trends in epidemiology of brain metastases: an overview.

Tabouret E, Chinot O, Metellus P, Tallet A, Viens P, Gonçalves A. Tabouret E, et al. Anticancer Res. 2012 Nov;32(11):4655-62. Anticancer Res. 2012. PMID: 23155227 Review.

5

Surgical resection of brain metastases from breast cancer in the modern era: clinical outcome and prognostic factors.

Tabouret E, Metellus P, Tallet-Richard A, Figarella-Branger D, Charaffe-Jauffret E, Viens P, Gonçalves A. Tabouret E, et al. Anticancer Res. 2013 May;33(5):2159-67. Anticancer Res. 2013. PMID: 23645770

6

Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma.

Tabouret E, Boudouresque F, Barrie M, Matta M, Boucard C, Loundou A, Carpentier A, Sanson M, Metellus P, Figarella-Branger D, Ouafik L, Chinot O. Tabouret E, et al. Neuro Oncol. 2014 Mar;16(3):392-9. doi: 10.1093/neuonc/not226. Epub 2013 Dec 9. Neuro Oncol. 2014. PMID: 24327581 Free PMC article.

7

High-grade glioma in elderly patients: can the oncogeriatrician help?

Tabouret E, Tassy L, Chinot O, Crétel E, Retornaz F, Rousseau F. Tabouret E, et al. Clin Interv Aging. 2013;8:1617-24. doi: 10.2147/CIA.S35941. Epub 2013 Dec 6. Clin Interv Aging. 2013. PMID: 24353408 Free PMC article. Review.

8

Bing-Neel syndrome: a cerebral Richter syndrome?

Tabouret E, Coso D, Matta M, Barrié M, Bouabdallah R, Chinot O. Tabouret E, et al. Neurol India. 2014 Mar-Apr;62(2):229-30. doi: 10.4103/0028-3886.132451. Neurol India. 2014. PMID: 24823755 Free article. No abstract available.

9

Predictive biomarkers investigated in glioblastoma.

Tabouret E, Chinot O, Sanson M, Loundou A, Hoang-Xuan K, Delattre JY, Idbaih A. Tabouret E, et al. Expert Rev Mol Diagn. 2014 Sep;14(7):883-93. doi: 10.1586/14737159.2014.945436. Epub 2014 Aug 5. Expert Rev Mol Diagn. 2014. PMID: 25096963 Review.

10

End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to Vinca-alkaloids in vitro and in vivo.

Berges R, Baeza-Kallee N, Tabouret E, Chinot O, Petit M, Kruczynski A, Figarella-Branger D, Honore S, Braguer D. Berges R, et al. Among authors: tabouret e. Oncotarget. 2014 Dec 30;5(24):12769-87. doi: 10.18632/oncotarget.2646. Oncotarget. 2014. PMID: 25473893 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters